Cited by 1,007Schizophrenia research and treatmentPsychometric Methodologies and TestingPsychological Testing and Assessment

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Kay, Stanley R., Opler, Lewis A., Lindenmayer, Jean-Pierre·1988·Psychiatry Research

DOI 10.1016/0165-1781(88)90038-8

Open this paper in CoChat — free account

Abstract

The Positive and Negative Syndrome Scale (PANSS) was developed out of the need for a well-operationalized method of assessing these syndromes in schizophrenia, including their relationship to one another and to global psychopathology. We surveyed 82 acute and chronic schizophrenics to analyze the psychometric properties of the four PANSS scales. The interrater reliabilities were in the 0.80's, and significant correlations emerged with corresponding criterion measures. The PANSS positive and negative scales were inversely intercorrelated once their shared association with general psychopathology had been partialed out. The results support the scales' reliability, criterion-related validity, and construct validity, while cross-validating some of our previous findings.

Integrity signals

Registry

Crossref · 10.1016/0165-1781(88)90038-8

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Untitled work
(1976) · Medical Entomology and Zoology · Cited by 8,899
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Negative v Positive Schizophrenia
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070025006 · Cited by 2,008
Positive and Negative Schizophrenic Symptoms and the Role of Dopamine
Crow, T. J. (1980) · The British Journal of Psychiatry · doi:10.1192/s0007125000071919 · Cited by 563
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 508
Symptomatic and Neuropsychological Components of Defect States
Bilder, R. M., Mukherjee, S., Rieder, R. O., & Pandurangi, A. K. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.409 · Cited by 504
Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia
Angrist, B., Rotrosen, J., & Gershon, S. (1980) · Psychopharmacology · doi:10.1007/bf00433802 · Cited by 344
Positive and negative symptoms in schizophrenia
Rosen, W. G., Mohs, R. C., Johns, C. A., Small, N. S., Kendler, K. S., Horvath, T., & Davis, K. L. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90075-1 · Cited by 238

Show all 28 references

Research works printed but not linked: 1

Kay, 1981, Arousal in schizophrenia: Toward a dual-process model and framework for research, JSAS Catalog of Selected Documents in Psychology, 11, 35

Sorted by citations

Items 701–800 of 998

Cuisine et schizophrénie : activité carrefour d’une évaluation écologique, ergothérapique et neuropsychologique
Stip, É., Sablier, J., Sepehry, A. A., Rivard, S., Cloutier, C., Aubin, G., Godbout, L., & Limoges, F. (2007) · Santé mentale au Québec · doi:10.7202/016514ar · Cited by 7
Stability of psychopathology dimensions in chronic schizophrenia: Response to clozapine treatment
Kay, S. R., & Lindenmayer, J. (1991) · Comprehensive Psychiatry · doi:10.1016/0010-440x(91)90067-m · Cited by 7
Assessment of Negative Symptoms: Instruments and Evaluation Criteria
Stieglitz, R. (1991) · Springer eBooks · doi:10.1007/978-3-642-76841-5_4 · Cited by 7
Neuroradiological Covariates of Drug-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenia
Sandyk, R., & Kay, S. R. (1991) · International Journal of Neuroscience · doi:10.3109/00207459108987181 · Cited by 7
Avatar Intervention in Virtual Reality for Cannabis Use Disorder in Individuals With Severe Mental Disorders: Results From a 1-Year, Single-Arm Clinical Trial
Giguère, S., Beaudoin, M., Dellazizzo, L., Phraxayavong, K., Potvin, S., & Dumais, A. (2024) · JMIR Mental Health · doi:10.2196/58499 · Cited by 10
Sex differences in the association between metabolic disorder and inflammatory cytokines in Han Chinese patients with chronic schizophrenia
Tian, Y., Li, Z., Zhang, Y., Tang, P. C., Zhuang, Y., Liu, L., Fan, H., Yao, X., Li, W., Xia, L., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1520279 · Cited by 6
Motivational Interviewing in Patients with Acute Psychosis: A Feasibility Study
Panchalingam, J., Horisberger, R., Corda, C., Kleisner, N., Krasnoff, J., Burrer, A., Spiller, T. R., Edkins, V., Seifritz, E., & Homan, P. (2025) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgaf004 · Cited by 6
Challenging the understanding of significant improvement and outcome in schizophrenia – the concept of reliable and clinically significant change methods
Schennach, R., Möller, H., Obermeier, M., Seemüller, F., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., et al. (2015) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1476 · Cited by 6
Prädiktoren für die Belastung von Angehörigen Schizophreniekranker
Friedrich, F., Unger, A., Freidl, M., Stelzig-Schöler, R., Rittmannsberger, H., Simhandl, C., Grill, W., Doby, D., & Wancata, J. (2012) · Psychiatrische Praxis · doi:10.1055/s-0032-1305318 · Cited by 6
Identifying improvable employment-related factors in schizophrenia patients
Hasegawa, T., Hashimoto, T., Kanahara, N., Yamanaka, H., Ishige, M., Sato, Y., & Iyo, M. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.05.064 · Cited by 6
Latent state-trait structure of BPRS subscales in clinical high-risk state and first episode psychosis
Hochstrasser, L., Studerus, E., Riecher‐Rössler, A., SCHIMMELMANN, B. G., Lambert, M., Lang, U. E., Borgwardt, S., Stieglitz, R., & Huber, C. G. (2022) · Scientific Reports · doi:10.1038/s41598-022-10207-x · Cited by 6
The impact of shadowboxing on the psychological well-being of professional martial artists
Croom, A. M. (2023) · Discover Psychology · doi:10.1007/s44202-023-00064-8 · Cited by 8
Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
Qiu, Y., Dong, Y., Sun, W., Li, G., Li, M. J., Zhao, Y., Jiang, C., & Li, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1144873 · Cited by 6
Comparison of male and female non-refugee immigrants with psychosis: clinical, sociodemographic, and migration-related differences and impact on stress
Trabsa, A., Casanovas, F., Pérez, V., Moreno‐Alcázar, A., Amann, B. L., & Mané, A. (2024) · Archives of Women s Mental Health · doi:10.1007/s00737-024-01431-7 · Cited by 6
Is conceptual implicit memory impaired in schizophrenia? Evidence from lexical decision and category verification
Marques, V. R. S., Spataro, P., Cestari, V., Sciarretta, A., Iannarelli, F., & Rossi‐Arnaud, C. (2014) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2014.957380 · Cited by 6
Parental and God Representations Among Individuals with Psychosis: A Grounded Theory Analysis
Prout, T. A., Ottaviano, P., Taveras, A., Sepulveda, C., & Torres, J. (2016) · Journal of Religion and Health · doi:10.1007/s10943-016-0265-0 · Cited by 6
Predictors of treatment satisfaction in antipsychotic-naïve and previously medicated patients with acute-phase psychosis
Stabell, L. A., Gjestad, R., Kroken, R. A., Løberg, E., Jørgensen, H. A., & Johnsen, E. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1636134 · Cited by 6
A Holistic Client Functioning Profile Comparison of People With Serious Mental Illness
Schmit, M. K., Oller, M. L., Tapia-Fuselier, J. L., & Schmit, E. L. (2020) · Journal of Counseling & Development · doi:10.1002/jcad.12295 · Cited by 7
Blood brain barrier permeability increases with age in individuals with 22q11.2 deletion syndrome
Taler, M., Mekori‐Domachevsky, E., Vergaelen, E., Claes, S. J., Serur, Y., Dar, S., Levy‐Shraga, Y., Weizman, A., Swillen, A., & Gothelf, D. (2021) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2021.2013090 · Cited by 6
Paranoid schizophrenia versus schizoaffective disorder: Neuropsychological aspects
Leposavić, L., Leposavić, I., Šaula-Marojević, B., & Gavrilovic, P. (2015) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1508391l · Cited by 6
Prevalence of depression in schizophrenic patients evaluated by the Calgary Depression Scale in Shebin El-Kom, Menoufiya
El-Bahy, M., & Mohamed, W. M. Y. (2013) · Middle East Current Psychiatry · doi:10.1097/01.xme.0000433781.14841.77 · Cited by 6
A novel approach to measuring response and remission in schizophrenia in clinical trials
Aboraya, A., Leucht, S., Nasrallah, H. A., Samara, M. T., Haro, J. M., Ahmed, E., & Zangeneh, M. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.03.020 · Cited by 6
Cost Utility Analysis
Franklin, M. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-55266-8_6 · Cited by 6
Effect of Transcranial Direct Current Stimulation on Functional Capacity in Schizophrenia: A Study Protocol for a Randomized Controlled Trial
Narita, Z. C., Inagawa, T., Maruo, K., Sueyoshi, K., & Sumiyoshi, T. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00233 · Cited by 6
Standardized Assessment of Psychopathology by Relatives of Mentally Disordered Patients
Nitsche, I., & Kallert, T. W. (2007) · Psychopathology · doi:10.1159/000101729 · Cited by 6
Critique of the Canadian Multicenter Placebo-Controlled Study of Risperidone and Haloperidol
Musser, W. S., & Kirisci, L. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199506000-00016 · Cited by 6
Étude contrôlée randomisée des effets de la pharmaco-éducation sur une population française de patients souffrant de troubles schizophréniques et schizoaffectifs
Maurel, M., Drai, D., Kaladjian, A., Pauly, V., & Azorin, J. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500509 · Cited by 6
An open clinical trial with clozapine in treatment-resistant schizophrenics.
Agarwal, A. K., Sharma, M., Srivastava, S., Mullick, M., & Kumar, A. (1997) · Europe PMC (PubMed Central) · Cited by 6
Die Bedeutung des 5-HT2-Rezeptor-Antagonismus für die Behandlung der Schizophrenie, unter spezieller Berücksichtigung der Minussymptomatik
Gelders, Y. G. (1990) · Springer eBooks · doi:10.1007/978-3-642-76263-5_22 · Cited by 6
Pomgulated methionil (LY2140023) in schizophrenia patients: a systematic review and meta-analysis
AbouShawareb, H., Abbas, O., Ghabour, H., Hassan, O., Shelbaya, A. N., Abdelsalam, R., & Meshref, M. M. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07199-z · Cited by 5
Analysis of selected polymorphisms in FOXP3 gene in a cohort of Egyptian patients with schizophrenia
Mostafa, M., Fathy, A. A., Elwasify, M., & Abdelsalam, M. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00371-y · Cited by 5
Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
Stabell, L. A., Johnsen, E., Kroken, R. A., Løberg, E., Blindheim, A. A., Joa, I., Reitan, S. K., Rettenbacher, M. A., Munk‐Jørgensen, P., & Gjestad, R. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04981-9 · Cited by 5
The Bidirectional Relationship between Weight Gain and Cognitive Function in First-Episode Schizophrenia: A Longitudinal Study in China
Ma, K., Zhou, T., Pu, C., Zhang, C., Han, X., Yang, L., & Yu, X. (2024) · Brain Sciences · doi:10.3390/brainsci14040310 · Cited by 5
Clinical, Quality of Life, and Health Care Utilization Outcomes of Switching the Administration Route of Antipsychotic Medications Among People With Schizophrenia Spectrum Disorder: A Systematic Review and Meta-Analysis
Kappi, A. A., Wang, T., Abufarsakh, B., & Okoli, C. T. C. (2024) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903241279605 · Cited by 5
Levels of Recovery From Psychotic Disorders Chart
Sousa, S. (1998) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/0279-3695-19981201-20 · Cited by 5
Electrocardiographic evaluation of the ventricular arrhythmia risk in patients with schizophrenia
Özsoy, F., Zorlu, Ç., & Kaya, Ş. (2020) · Anatolian Journal of Psychiatry · doi:10.5455/apd.7015 · Cited by 5
The Correlation of PANSS Scores and P100 Latency in Patients with Schizophrenia and Migrene Hedache Using Visual Evoked Potentials (VEPS) According to Gender and Age
Sulejmanpašić, G., Memić-Serdarević, A., Šabanagić-Hajrić, S., & Bajramagic, N. (2022) · Acta Informatica Medica · doi:10.5455/aim.2022.30.318-323 · Cited by 5
“InMotion”—Mixed physical exercise program with creative movement as an intervention for adults with schizophrenia: study protocol for a randomized controlled trial
Poikonen, H., Duberg, A., Eriksson, M. H., Crommert, M. E., Lund, M., Möller, M., & Msghina, M. (2023) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2023.1192729 · Cited by 5
A study of contingent negative variation and post-imperative negative variation: search for state and trait electrophysiological markers in schizophrenia.
Simlai, J., Nizamie, S. H., & Khess, C. R. J. (2010) · PubMed · Cited by 5
Factors discriminating employment status following in-patient evaluation among persons with schizophrenia
Lipskaya‐Velikovsky, L., Kotler, M., & Jarus, T. (2016) · Work · doi:10.3233/wor-152178 · Cited by 5
Changes in delusional dimensions and emotions over eight weeks of antipsychotic treatment in acute patients
So, S. H., PETERS, E. R., Kapur, S., & Garety, P. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.027 · Cited by 6
Clinical correlates of objective and subjective quality of life among middle-aged and elderly female inpatients with chronic schizophrenia
Nakagawa, S., & Hayashi, N. (2013) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2013.03.015 · Cited by 5
Critical trial-related criteria in acute schizophrenia studies
Riedel, M. J., Leucht, S., Rüther, E., Schmauß, M., & Möller, H. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0225-3 · Cited by 5
Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes
Lee, A. A., McKibbin, C. L., Bourassa, K. A., Wykes, T. L., & Andren, K. A. K. (2014) · Psychosomatics · doi:10.1016/j.psym.2013.12.015 · Cited by 5
From hospital admission to independent living: Is prediction possible?
Lipskaya‐Velikovsky, L., Kotler, M., Easterbrook, A., & Jarus, T. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.01.027 · Cited by 6
An open multicentre pilot study examining the safety, efficacy and tolerability of fast titrated (800 mg/day by day 4) quetiapine in the treatment of schizophrenia/schizoaffective disorder
Peuskens, J., Devoitille, J.-M., Kusters, J., & Vandenhoven, G. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500802085369 · Cited by 5
Neurocognitive Functions in Patients With Remitted and Nonremitted Schizophrenia: A Cross-Sectional Study
Kurebayashi, Y., & Otaki, J. (2016) · Perspectives In Psychiatric Care · doi:10.1111/ppc.12195 · Cited by 5
Association of Candidate Single Nucleotide Polymorphisms Related to Candidate Genes in Patients With Schizophrenia
Karimian, S. S., Akbari, M. T., Sadr, S. S., & Javadi, G. (2020) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.9.10.470 · Cited by 5
Is it possible to combine different psychotic symptom scales in bipolar disorder?
Fernandez-Garcimartín, H., Bagney, A., Moreno-Ortega, M., Dompablo, M., Torío, I., Lobo, A., Jimenez-Arriero, M. Á., Palomo, T., & Rodríguez–Jiménez, R. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.018 · Cited by 5
In vivo type II T-helper cells shift in schizophrenia compared to sex- and age-matched healthy controls
Chiang, S. S. W., Riedel, M. J., Gruber, R., Müller, N., & Schwarz, M. (2011) · The European Journal of Psychiatry · doi:10.4321/s0213-61632011000400002 · Cited by 5
Two case studies from a virtual reality intervention for delusions: feasibility and preliminary evidence
Dietrichkeit, M., Flint, K., Krieger, E. C., Grzella, K., Nagel, M., & Moritz, S. (2018) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x18000090 · Cited by 5
Secretagogin may not be a new neuroendocrine biomarker in schizophrenia while levels may reflect clinical severity
Erzın, G., Topçuoğlu, C., Bayram, Ş., Karadağ, H., Özkaya, G., Turhan, T., & Göka, E. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1589175 · Cited by 5
Effects of needs-assessment-based psycho-education of schizophrenic patients' families on the severity of symptoms and relapse rate of patients.
Kheirabadi, G. R., Rafizadeh, M., Omranifard, V., Yari, A., Maracy, M. R., Mehrabi, T., & Sadri, S. (2014) · PubMed Central · Cited by 5
FUNCIONAMIENTO PSICOSOCIAL DE PACIENTES ESQUIZOFRÉNICOS DE ACUERDO CON SU CONSUMO DE ALCOHOL
Salcedo, V. V., Collazos, M. V., Martínez, L. R. D., Icaza, M. E. M. M., & Juárez, F. (2005) · Salud Mental · Cited by 5
Generalizability in NonGaussian Longitudinal Clinical Trial Data Based on Generalized Linear Mixed Models
Vangeneugden, T., Molenberghs, G., Laenen, A., Alonso, A., & Geys, H. (2008) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543400802071386 · Cited by 5
Duration of untreated psychosis is associated with more negative schizophrenia symptoms after acute treatment for first-episode psychosis
Granö, N., Lindsberg, J., Karjalainen, M., Grönroos, P., & Blomberg, A.-P. (2010) · Clinical Psychologist · doi:10.1080/13284201003662826 · Cited by 5
Use of primary care by middle aged and older persons with schizophrenia
Folsom, D. P., McKibbin, C. L., Jeste, D. V., & Patterson, T. L. (2007) · Primary Care and Community Psychiatry · doi:10.1185/135525706x121174 · Cited by 5
Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project
Brown, E. S., Rush, A. J., Biggs, M. M., Shores‐Wilson, K., Carmody, T. J., & Suppes, T. M. (2003) · Psychiatry Research · doi:10.1016/s0165-1781(02)00322-0 · Cited by 5
Relationship between public and private self-focused attention and auditory verbal hallucinations as an interpersonal process
Garcelán, S. P., Úbeda-Gómez, J., León-Palacios, M. G., Escudero-Pérez, S., Barros-Albarrán, M. D., López‐Jiménez, A. M., Vallina-Fernández, Ó., Jiménez-García-Bóveda, R., Diez-Alegría, C., Testal, J. F. R., et al. (2015) · Psychosis · doi:10.1080/17522439.2015.1115540 · Cited by 5
The stability of symptoms and syndromes in chronic schizophrenic patients.
Borde, M., Davis, E. J., & Sharma, L. (1992) · PubMed Central · Cited by 5
Proper Names and Noun-to-Determiner Movement in Aphasia: A Case Study
Semenza, C., Granà, A., Cocolo, R., Longobardi, G., & Benedetto, P. D. (2002) · Brain and Cognition · doi:10.1006/brcg.2001.1414 · Cited by 5
Using preference based measures in mental health conditions: The psychometric validity of the EQ-5D and SF-6D
Mulhern, B. J., Mukuria, C., Barkham, M., Knapp, M. R. J., Byford, S., Soeteman, D. I., & Brazier, J. E. (2013) · White Rose Research Online (University of Leeds, The University of Sheffield, University of York) · Cited by 5
Neuroradiological Facets of Cognitive Abnormality in Schizophrenia
Kay, S. R., Sandyk, R., & Merriam, A. E. (1991) · International Journal of Neuroscience · doi:10.3109/00207459108987185 · Cited by 5
Duration of untreated psychosis and associated sociodemographic and clinical factors in first-episode psychosis: A study from Eastern Nepal
Limbu, S., Nepal, S., & Mishra, S. K. (2024) · The International Journal of Psychiatry in Medicine · doi:10.1177/00912174241247611 · Cited by 4
Exploring the Association Between Heavy Metals, TNF-α Regulation, and Cognitive Dysfunction in Schizophrenia
Ray, A., Tomo, S., Yadav, D., Banerjee, M., Sharma, P., Sharma, S., Nebhinani, N., Birdi, A., Pawar, H., & Janu, V. C. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04701-2 · Cited by 4
The association between fear of COVID-19 and depression, anxiety, and psychosis among Lebanese chronic patients with schizophrenia: any moderating effect of spirituality?
Bitar, Z., Haddad, C., Obeïd, S., & Hallit, S. R. (2022) · Croatian Medical Journal · doi:10.3325/cmj.2022.63.412 · Cited by 4
COMT and Neuregulin 1 Markers for Personalized Treatment of Schizophrenia Spectrum Disorders Treated with Risperidone Monotherapy
Bondrescu, M., Dehelean, L., Farcaş, S. S., Papavă, I., Nicoras, V., Mager, D. V., Grecescu, A. E., Podaru, P. A., & Andreescu, N. I. (2024) · Biomolecules · doi:10.3390/biom14070777 · Cited by 4
Neural Correlates of the Preserved Inhibition of Return in Schizophrenia
Tang, Y., Li, Y., Zhuo, K., Wang, Y., Liao, L., Song, Z., Li, H., Fan, X., GOFF, D. C., Wang, J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119521 · Cited by 4
Reconnaître les symptômes psychiatriques iatrogènes liés aux antipsychotiques
Demily, C., Chouinard, V., & Chouinard, G. (2010) · L Encéphale · doi:10.1016/j.encep.2010.01.003 · Cited by 4
An association study of the HSPA8 gene polymorphisms with schizophrenia in a Polish population
Kowalczyk, M., Owczarek, A. J., Suchanek-Raif, R., Kucia, K. A., & Kowalski, J. (2021) · Cell Stress and Chaperones · doi:10.1007/s12192-021-01249-7 · Cited by 4
Linked patterns of interhemispheric functional connectivity and microstructural characteristics of the corpus callosum in antipsychotic-naive first-episode schizophrenia
Bo, T., Xiao, Y., Li, B., Yu, W., Zhu, F., Gao, Z., Cao, H., Gong, Q., Gu, S., Qiu, C., et al. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103659 · Cited by 4
Activity Based Group Intervention in Improving Negative Symptoms and Functional Outcome in Patients with Chronic Schizophrenia in Welfare Homes
Ravindren, R. K., Shibukumar, T. M., Lekshmi, B., & Jose, K. (2018) · Journal of Psychosocial Rehabilitation and Mental Health · doi:10.1007/s40737-018-0116-2 · Cited by 4
Trauma and Suicide
Allen, A. R., & Hagen, K. M. (2020) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001144 · Cited by 5
Evaluation of a Collaborative Care Program for Patients With Treatment-Resistant Schizophrenia: Protocol for a Multiple Case Study
Jongkind, A., Hendriks, M. C. P., Grootens, K. P., Beekman, A. T. F., & van Meijel, B. (2022) · JMIR Research Protocols · doi:10.2196/35336 · Cited by 4
Amphetamine Versus Non Amphetamine-Related First Episode Psychosis in Saudi Arabian Patients
Desoky, E. S. E., El-Tantawy, A., Raya, Y. M., & Al-Yahya, A. (2011) · Pharmacology & Pharmacy · doi:10.4236/pp.2011.23013 · Cited by 4
The Effects of Task Engagement and Interpersonal Rapport onWCSTPerformance in Schizophrenia
Roberts, D. L., & Penn, D. L. (2009) · American Journal of Psychiatric Rehabilitation · doi:10.1080/15487760802615798 · Cited by 4
Subjectivity in the Perception and Measurement of Quality of Life: Conceptualization and Development of the Seville Questionnaire
Giner, J., Ibáñez, E., Franco, D., & Alarcón, R. D. (2008) · Psychiatric Quarterly · doi:10.1007/s11126-008-9086-y · Cited by 4
Biological Determinants and Risk Factors for Tardive Dyskinesia in Schizophrenia
Sandyk, R. (1993) · International Journal of Neuroscience · doi:10.3109/00207459309003314 · Cited by 4
Family Aided Community Treatment for the Treatment of Early Psychosis: A Proof of Concept Study
Melton, R. P., & Dykeman, C. (2016) · Community Mental Health Journal · doi:10.1007/s10597-015-9984-z · Cited by 4
Xanomeline and Trospium Chloride
Beninger, P. R. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.10.001 · Cited by 4
Risk factors for suicidality across psychosis vulnerability spectrum
Stephan, N. M., van Sprang, E. D., Wiebenga, J. X. M., Dickhoff, J., Schirmbeck, F. N., de Haan, L., van Amelsvoort, T., Veling, W., Alizadeh, B. Z., Simons, C. J. P., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.09.021 · Cited by 3
The Impact of Childhood Trauma on the Negative Symptoms of Schizophrenia
Ware, K., Misiak, B., Hamza, E. A., Nalla, S., & Moustafa, A. A. (2024) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001788 · Cited by 7
A retrospective case-control study of facial emotion recognition in male veterans with chronic schizophrenia and its correlation with interpersonal communication
Wang, Y., Wang, X.-F., Shi, L.-D., Xu, X., Wei, L., Li, S.-S., Li, X.-P., Ma, X.-L., Li, Z.-M., Wei, X.-Z., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04498-7 · Cited by 3
Into a Deeper Understanding of CYP2D6’s Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders
Bondrescu, M., Dehelean, L., Farcaş, S. S., Dragan, P. A., Podaru, C. A., Popa, L. C., & Andreescu, N. I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126350 · Cited by 3
Personal recovery and future self-continuity in individuals with schizophrenia
Demirli, E., Ahmed, A. O., & Serper, M. R. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116510 · Cited by 3
Relación entre trauma, disociación y síntomas psicóticos positivos
Castro-Fernández, M. D. P., Garcelán, S. P., Senín‐Calderón, C., & Testal, J. F. R. (2015) · Acción Psicológica · doi:10.5944/ap.12.2.15824 · Cited by 3
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder – When, Who, and How?
Schennach, R., Obermeier, M., Seemüller, F., Jäger, M., Schmauß, M., Laux, G., Pfeiffer, H., Naber, D., Schmidt, L., Gäebel, W., et al. (2017) · Pharmacopsychiatry · doi:10.1055/s-0043-106436 · Cited by 3
Symptom remission and functional outcome in an Egyptian sample of patients with schizophrenia
El-Ghamry, R. H., Saad, A. E., Elbatrawy, A. N., Hassan, G. A. M., Rabie, E. S., & Mohamed, M. Y. (2021) · Middle East Current Psychiatry · doi:10.1186/s43045-021-00156-y · Cited by 3
Hippocampal Network Dysfunction in Early Psychosis: A 2-Year Longitudinal Study
Avery, S. N., Rogers, B. P., McHugo, M., Armstrong, K., Blackford, J. U., Vandekar, S., Woodward, N. D., & Heckers, S. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.10.002 · Cited by 3
Relationship of chronotype and sleep quality with crime in schizophrenia patients in the high-security forensic psychiatry clinic
Emir, B. S., Kılıçaslan, A. K., Yıldız, S., & Kurt, O. (2023) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21729 · Cited by 3
Level of structural integration in people with schizophrenia and schizoaffective disorders - applicability and associations with clinical parameters
Bayer, S., Bröcker, A., Stuke, F., Just, S. A., Bertram, G., Grimm, I., Maaßen, E., Büttner, M., Heinz, A., Bermpohl, F., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1388478 · Cited by 3
Smartphone video games for cognitive functions and negative symptoms in male with chronic schizophrenia: A randomized controlled trial
Wang, W., Ye, M., Zhong, Y., Zhang, M., Wang, Y., Chen, C., Yao, Y., Feng, Z., Yuan, X., Shi, S., et al. (2025) · Heliyon · doi:10.1016/j.heliyon.2025.e42049 · Cited by 3
Health-related quality of life in Schizophrenia: the use of SF-36 direct and standardized scores.
Campos, R. P. (2012) · Cureus · doi:10.7759/cureus.57 · Cited by 3
Increased brain-derived neurotrophic factor exon IV histone 3 lysine 9 dimethylation in patients with schizophrenia
Huang, T., Hsieh, M.-T., & Lin, C.-C. (2019) · Taiwanese Journal of Psychiatry · doi:10.4103/tpsy.tpsy_18_19 · Cited by 3
Preserved priming effect in individuals with schizophrenia: cues towards rehabilitation
Lessard, N., McNally-Gagnon, A., Dubuc, M.-J., Forget, J., Mottard, J., Leblanc, J., & Lassonde, M. C. (2015) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2015.1100111 · Cited by 3
Antipsychotic Combination with Psychosocial Intervention on Outcome of Schizophrenia (ACPIOS): Rationale and Design of the Clinical Trial
Guo, X., Zhao, J., Liu, Z., Zhai, J., Xue, Z., & Chen, J. (2007) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.1.2.9 · Cited by 3
Gender differences in schizophrenia observations from Northern Finland
Räsänen, S. (2000) · Cited by 3
Development and Preliminary Evaluation of a Social Cognition Intervention for Outpatients with Schizophrenia Spectrum Disorders
Roberts, D. L. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/87wh-yh18 · Cited by 3
Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia
Benelmokhtar, J. M., Chiliza, B., Phahladira, L. S., Emsley, R. A., & Asmal, L. (2021) · South African Journal of Psychiatry · doi:10.4102/sajpsychiatry.v27i0.1657 · Cited by 3
Metacognitive change as a predictor of outcome in cognitive therapy for psychosis.
Parker, S., Adrian Wells, A., & Morrison, A. P. (2014) · PubMed · Cited by 3

Authors: Kay, S. R., Opler, L. A., & Lindenmayer, J.-P.
Affiliations: Albert Einstein College of Medicine (US)
ORCID: Opler, Lewis A.
Lindenmayer, Jean-Pierre
Venue: Psychiatry Research
Publisher: Elsevier BV
Published: 1988-01
Volume: 23
Issue: 1
Pages: 99-110
ISSN: 0165-1781 (ISSN-L)
DOI: 10.1016/0165-1781(88)90038-8
OpenAlex: W2100828552
Cited by: 1,007
References: 28
Citations by year: 2026: 16 · 2025: 30 · 2024: 38 · 2023: 28 · 2022: 33 · 2021: 43 · 2020: 33 · 2019: 37 · 2018: 41 · 2017: 33 · 2016: 45 · 2015: 49 · 2014: 37 · 2013: 40 · 2012: 44
FWCI: 8.23
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Psychiatry Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Keywords: PANSS, schizophrenia, psychometric properties, inter-rater reliability, criterion validity, construct validity, positive symptoms, negative symptoms, cross-validation
MeSH terms: Adult, Female, Humans, Male, Prognosis, Psychiatric Status Rating Scales, Psychometrics, Schizophrenia, Schizophrenic Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reliability and validity of the positive and negative syndrome scale for schizophrenics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks